Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

4.5K
Commitment is the  process whereby stem cells:
4.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Hematopoiesis01:21

Hematopoiesis

9.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.7K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Itching Symposium.

L'union medicale du Canada·2010
Same author

Evaluation and presentation of forensic DNA evidence in European laboratories.

Science & justice : journal of the Forensic Science Society·2002
Same author

Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families.

Human heredity·2001
Same author

Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history.

International journal of cancer·2001
Same author

Does use of an instant hand sanitizer reduce elementary school illness absenteeism?

The Journal of family practice·2001
Same author

The impact of the principles of evidence interpretation on the structure and content of statements.

Science & justice : journal of the Forensic Science Society·2000

Related Experiment Video

Updated: Mar 21, 2026

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.8K

SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.

T Hoang1, J A Lambert1, R Martin1

  • 1Laboratory of Hematopoiesis and Leukemia, Institute of Research in Immunology and Cancer (IRIC), University of Montreal, Montreal, QC, Canada.

Current Topics in Developmental Biology
|May 4, 2016
PubMed
Summary
This summary is machine-generated.

The SCL transcription factor is crucial for blood cell development (hematopoiesis) and stem cell reprogramming. It plays key roles from early development through stress responses and can initiate leukemia under certain conditions.

Keywords:
Cellular reprogrammingDevelopmental hematopoiesisE2A/TCF3HEB/TCF12Hematopoietic stem cellsNOTCH1Preleukemic stem cellsSCL/TAL1Self-renewalVEGF

More Related Videos

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
11:40

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

8.9K
Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
11:42

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

6.6K

Related Experiment Videos

Last Updated: Mar 21, 2026

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.8K
Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
11:40

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

8.9K
Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors
11:42

Hemogenic Reprogramming of Human Fibroblasts by Enforced Expression of Transcription Factors

Published on: November 4, 2019

6.6K

Area of Science:

  • Developmental Biology
  • Hematopoiesis
  • Stem Cell Biology

Background:

  • SCL (Stem Cell Leukemia) is a master regulator of hematopoiesis, specifying mesoderm to blood cell fates and inhibiting cardiac lineages.
  • It collaborates with factors like Vegfa/Flk1 for primitive hematopoiesis and Runx1/Gata2 for definitive hematopoietic stem cells (HSCs).
  • While redundant with Lyl1 in steady-state HSCs, SCL is vital for stress-induced HSC activation.

Purpose of the Study:

  • To elucidate the multifaceted roles of the SCL transcription factor in hematopoiesis and stem cell regulation.
  • To understand the molecular mechanisms of SCL-mediated transcriptional activation and its role in cell fate determination.
  • To investigate the potential of SCL in reprogramming somatic cells and its implication in leukemogenesis.

Main Methods:

  • Analysis of SCL's role in embryonic development and hematopoietic stem cell emergence.
  • Investigation of SCL's interaction with co-factors (E2A/HEB, GATA factors, LMO/LDB proteins, RUNX1, ERG, FLI1) in transcriptional regulation.
  • Experimental manipulation of SCL and associated factor expression in thymocytes and fibroblasts for reprogramming studies.

Main Results:

  • SCL specifies mesoderm to hematopoietic fate, regulates primitive and definitive hematopoiesis, and is essential for stress hematopoiesis.
  • SCL recruits a multi-protein complex to DNA, enabling control over cell proliferation and differentiation.
  • Ectopic expression of SCL and co-factors can reprogram cells into preleukemic stem cells and hematoendothelial cells, highlighting their role in cell fate conversion.

Conclusions:

  • SCL is a pivotal regulator of hematopoiesis with diverse functions across developmental stages and stress conditions.
  • The SCL-mediated transcriptional complex is adaptable, controlling distinct cellular outcomes.
  • SCL and its interacting partners are critical for hematopoietic reprogramming, with potential implications for understanding and treating T-cell acute lymphoblastic leukemias.